Omeros (OMER) Accumulated Depreciation (2011 - 2026)
Omeros (OMER) posted Accumulated Depreciation of $12.3 million for Q1 2026, up 1.99% sequentially from $12.0 million in Q4 2025, and up 8.05% YoY from $11.4 million in Q1 2025.
Omeros (OMER) Accumulated Depreciation (2011 - 2026) Analysis & Trends
Omeros has reported Accumulated Depreciation for 11 years, with the latest figure at $12.3 million in Q1 2026.
- Quarterly Accumulated Depreciation rose 8.05% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 8.05% YoY) and the FY2025 annual result came in at $12.0 million, up 8.71% from the prior year.
- Accumulated Depreciation improved to $12.3 million in Q1 2026 per OMER's latest filing, from $12.0 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $12.3 million in Q1 2026 and troughed at $9.3 million in Q1 2022.
- A 5-year average of $10.6 million and a median of $10.4 million in 2024 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation increased 15.85% in 2022, then advanced 2.11% in 2023.
- Over 5 years, Accumulated Depreciation stood at $9.5 million in 2022, then climbed by 7.26% to $10.2 million in 2023, then rose by 8.11% to $11.1 million in 2024, then advanced by 8.71% to $12.0 million in 2025, then gained by 1.99% to $12.3 million in 2026.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $12.3 million, $12.0 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.47 Mn |
| Mar 31, 2026 | 12.28 Mn |
| Dec 31, 2025 | 12.04 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 11.36 Mn |
| Dec 31, 2024 | 11.07 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 10.24 Mn |
| Sep 30, 2023 | 10.04 Mn |
| Jun 30, 2023 | 9.84 Mn |
| Mar 31, 2023 | 9.51 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 9.76 Mn |
| Jun 30, 2022 | 9.44 Mn |
| Mar 31, 2022 | 9.31 Mn |
| Dec 31, 2021 | 9.03 Mn |
| Sep 30, 2021 | 8.71 Mn |